NCT01846234|Completed
Sodium Intake in Multiple Sclerosis
SALT
Effect of Sodium Intake in Multiple Sclerosis Disease Activity
Loading search results
SALT
Effect of Sodium Intake in Multiple Sclerosis Disease Activity
Sponsor study identifier
Secondary identifiers
OTHER_GRANT · FLENI
observational
132
1 country
1
Study Start
November 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
July 2013
Actual (reported)Study Completion
July 2013
Actual (reported)Recently, it has been shown that salt (ClNa, sodium chloride) can modulate the differentiation of human and mouse TH17 cells. Indeed, mice feed with high sodium diet were described to develop more aggressive course of EAE (Experimental Autoimmune Encephalitis). However, the role of sodium intake in MS has not been investigated. In this study we investigate the effect of sodium intake in Multiple Sclerosis (MS) clinical and radiological activity.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 2013
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 2010
Date type not reportedThis date has not been verified as actual or estimated.
May 1, 2013
Actual (reported)May 3, 2013
Actual (reported)July 2013
Actual (reported)July 2013
Actual (reported)Exacerbation rate
Number of disease relapses during follow up time according to salt consumption
2 years
Radiological activity
One year
MS patients
A total of 70 patients with relapsing-remitting MS according to McDonald criteria1 were recruited from the MS clinic at FLENI by attending neurologists. A second group of 52 relapsing-remitting MS patients was recluted later.
FLENI
Buenos Aires, 1428, Argentina
Blood, urine
Mauricio F Farez, MD MPH
Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia
132 participants (actual enrollment reported by the registry).
First Submitted
May 1, 2013
First Posted
May 3, 2013
Study Start
November 2010
Date type not reportedThis date has not been verified as actual or estimated.
Correlation Between Relapses in Multiple Sclerosis (MS) and Vitamin D Intake
Contact the study team to confirm eligibility.
Primary Completion
July 2013
Actual (reported)Study Completion
July 2013
Actual (reported)Last Updated
October 22, 2013
Record last verified: 2013-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: